Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-24-050751
Filing Date
2024-06-07
Accepted
2024-06-07 16:00:55
Documents
12
Effectiveness Date
2024-06-07

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0207285-s8_jasper.htm S-8 66131
2 JASPER THERAPEUTICS, INC. 2024 EQUITY INCENTIVE PLAN ea020728501ex4-3_jasper.htm EX-4.3 169644
3 FORM OF STOCK OPTION AWARD AGREEMENT UNDER THE JASPER THERAPEUTICS, INC. 2024 EQ ea020728501ex4-4_jasper.htm EX-4.4 64653
4 FORM OF RESTRICTED STOCK UNIT AWARD AGREEMENT UNDER THE JASPER THERAPEUTICS, INC ea020728501ex4-5_jasper.htm EX-4.5 50080
5 FORM OF RESTRICTED STOCK AWARD AGREEMENT UNDER THE JASPER THERAPEUTICS, INC. 202 ea020728501ex4-6_jasper.htm EX-4.6 31845
6 JASPER THERAPEUTICS, INC. 2024 EMPLOYEE STOCK PURCHASE PLAN ea020728501ex4-7_jasper.htm EX-4.7 84325
7 OPINION OF PAUL HASTINGS LLP ea020728501ex5-1_jasper.htm EX-5.1 16217
8 CONSENT OF PRICEWATERHOUSECOOPERS LLP ea020728501ex23-1_jasper.htm EX-23.1 1270
9 FILING FEE TABLE ea020728501ex-fee_jasper.htm EX-FILING FEES 51103
10 GRAPHIC ex5-1_001.jpg GRAPHIC 8783
11 GRAPHIC ex5-1_002.jpg GRAPHIC 9736
12 GRAPHIC ex5-1_003.jpg GRAPHIC 6204
  Complete submission text file 0001213900-24-050751.txt   570919
Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Filer) CIK: 0001788028 (see all company filings)

EIN.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-280039 | Film No.: 241029156
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)